When you develop and produce active pharma ingredients (API’s), there are always some impurities – identifying the chemical structure of the known ones is usually not a problem, but what about the unknown?

Whether the impurities are process-related or coming from the degradation of products they always need to be identified and classified accordingly.

With some of the best chemists in the industry using state of the art science and lab techniques, it now really is possible to identify the unidentified!

At QUINTA-ANALYTICA we offer structure elucidation, characterization, and full certification in both Research and Development (R&D) or Good Manufacturing Practice (GMP) mode. Our specialist labs are even able to do isotopically labeled compound enrichment.

With a global approach to business and multiple labs within central Europe, Quinta-Analytica is your true pharma partner.

Contact us today to learn more about the catalog of services we offer.

Additional News

  • 16 April 2026

    Expanding Beyond FDA & EMA: Strengthening Our Global Regulatory Footprint with GCC

    Quinta-Analytica has successfully completed a full on-site GCP inspection within the GCC framework, further strengthening its international regulatory footprint and clinical research credibility.

  • 25 March 2026

    ADC Webinar: DAR, Bioanalysis and Intact MS in Next-Generation ADC Development

    On behalf of Conscio Group, registration is now open for our free expert-led webinar on DAR characterization, bioanalytical strategy and mass spectrometry insight in ADC development.

  • 17 December 2025

    PF 2026: Thank You from Quinta-Analytica

    In 2025, Quinta-Analytica continued to turn complex development challenges into tangible progress. Our PF 2026 message looks back at key milestones and thanks the partners, clients, and teams who made them possible.